NLRP3 and hypertensive disorder: We found that Ang II induced significant and similar increase of SBP in mitoTEMPO-treated and NLRP3 KO mice compared to the WT controls, demonstrating the hypertension-independent protection of mitoTEMPO and NLRP3 deletion (Figure 5C).